Gianni Simone

Molecular Profiling of Inflammatory Breast Cancer

High cyclin B1 expression is associated with poor survival in breast cancer

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Triple-negative breast cancer molecular subtyping and treatment progress

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Inflammatory breast cancer: a review.

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Gene therapy in pancreatic cancer

Pyroptosis: mechanisms and diseases

The current understanding of the molecular determinants of inflammatory breast cancer metastasis

Hormone receptors in malignancy

Collective cell migration in morphogenesis, regeneration and cancer

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

The history and future of targeting cyclin-dependent kinases in cancer therapy

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition

Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer

Breast Cancer Treatment

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer

Delineation of HER2 Gene Status in Breast Carcinoma by Silver in Situ Hybridization is Reproducible among Laboratories and Pathologists

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease

Topoisomerase‐I, thymidylate synthase primary tumour expression and clinical efficacy of 5‐FU/CPT‐11 chemotherapy in advanced colorectal cancer patients

Prognostic relevance of histological grade and its components in node-negative breast cancer patients

Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.

Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions